A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Tóm tắt
Từ khóa
Tài liệu tham khảo
Larrick, 1991, Complementary DNA sequence of rabbit CAP18–a unique lipopolysaccharide binding protein, Biochem. Biophys. Res. Commun., 179, 170, 10.1016/0006-291X(91)91350-L
Larrick, 1993, Antimicrobial activity of rabbit CAP18-derived peptides, Antimicrob. Agents Chemother., 37, 2534, 10.1128/AAC.37.12.2534
Larrick, 1995, Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein, Infect. Immun., 63, 1291, 10.1128/IAI.63.4.1291-1297.1995
Cowland, 1995, HCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules, FEBS Lett., 368, 173, 10.1016/0014-5793(95)00634-L
Overhage, 2008, Human host defense peptide LL-37 prevents bacterial biofilm formation, Infect. Immun., 76, 4176, 10.1128/IAI.00318-08
Dean, 2011, Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: d-enantiomer of LL-37, Front. Microbiol., 2, 128, 10.3389/fmicb.2011.00128
Amer, 2010, Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella, Biochem. Biophys. Res. Commun., 396, 246, 10.1016/j.bbrc.2010.04.073
Murakami, 2004, Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense, J. Immunol., 172, 3070, 10.4049/jimmunol.172.5.3070
Wong, 2011, Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans, Peptides, 32, 1996, 10.1016/j.peptides.2011.08.018
Barlow, 2011, Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37, PLoS One, 6, e25333, 10.1371/journal.pone.0025333
Howell, 2004, Selective killing of vaccinia virus by LL-37 implications for eczema vaccinatum, J. Immunol., 172, 1763, 10.4049/jimmunol.172.3.1763
Gordon, 2005, Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity, Curr. Eye Res., 30, 385, 10.1080/02713680590934111
Wong, 2011, Effects of cathelicidin and its fragments on three key enzymes of HIV-1, Peptides, 32, 1117, 10.1016/j.peptides.2011.04.017
Davidson, 2004, The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization, J. Immunol., 172, 1146, 10.4049/jimmunol.172.2.1146
Koczulla, 2003, An angiogenic role for the human peptide antibiotic LL-37/hCAP-18, J. Clin. Invest., 111, 1665, 10.1172/JCI17545
Coffelt, 2009, The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells, Proc. Natl. Acad. Sci. USA, 106, 3806, 10.1073/pnas.0900244106
Pfosser, 2010, NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37, Stem Cells, 28, 376, 10.1002/stem.280
Carretero, 2008, In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37, J. Invest. Dermatol., 128, 223, 10.1038/sj.jid.5701043
Turner, 1998, Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils, Antimicrob. Agents Chemother., 42, 2206, 10.1128/AAC.42.9.2206
Joly, 2004, Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms, J. Clin. Microbiol., 42, 1024, 10.1128/JCM.42.3.1024-1029.2004
Wang, 2008, Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins, Antimicrob. Agents Chemother., 52, 3438, 10.1128/AAC.00452-08
Quinones-Mateu, 2003, Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication, AIDS, 17, F39, 10.1097/00002030-200311070-00001
Hase, 2003, Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori, Gastroenterology, 125, 1613, 10.1053/j.gastro.2003.08.028
Grigat, 2007, Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family, J. Immunol., 179, 3958, 10.4049/jimmunol.179.6.3958
Territo, 1989, Monocyte-chemotactic activity of defensins from human neutrophils, J. Clin. Invest., 84, 2017, 10.1172/JCI114394
Van, 1997, Effect of defensins on interleukin-8 synthesis in airway epithelial cells, Am. J. Physiol., 272, L888
Lillard, 1999, Mechanisms for induction of acquired host immunity by neutrophil peptide defensins, Proc. Natl. Acad. Sci. USA, 96, 651, 10.1073/pnas.96.2.651
Niyonsaba, 2010, Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells, J. Immunol., 184, 3526, 10.4049/jimmunol.0900712
Chromek, 2006, The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection, Nat. Med., 12, 636, 10.1038/nm1407
Nizet, 2001, Innate antimicrobial peptide protects the skin from invasive bacterial infection, Nature, 414, 454, 10.1038/35106587
Iimura, 2005, Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens, J. Immunol., 174, 4901, 10.4049/jimmunol.174.8.4901
Howell, 2006, Cathelicidin deficiency predisposes to eczema herpeticum, J. Allergy Clin. Immunol., 117, 836, 10.1016/j.jaci.2005.12.1345
Morioka, 2008, Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis, J. Immunol., 181, 3915, 10.4049/jimmunol.181.6.3915
Doring, 2012, Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice, Circ. Res., 110, 1052, 10.1161/CIRCRESAHA.112.265868
Liu, 2007, Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin, J. Immunol., 179, 2060, 10.4049/jimmunol.179.4.2060
Tai, 2007, A new role for cathelicidin in ulcerative colitis in mice, Exp. Biol. Med. (Maywood), 232, 799
Ong, 2002, Endogenous antimicrobial peptides and skin infections in atopic dermatitis, N. Engl. J. Med., 347, 1151, 10.1056/NEJMoa021481
Heilborn, 2003, The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium, J. Invest. Dermatol., 120, 379, 10.1046/j.1523-1747.2003.12069.x
Morizane, 2011, Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands, J. Invest. Dermatol.
Yamasaki, 2007, Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea, Nat. Med., 13, 975, 10.1038/nm1616
Buchau, 2010, The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth, J. Immunol., 184, 369, 10.4049/jimmunol.0902110
Chuang, 2008, Treatment with LL-37 peptide enhances the antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer, Hum. Gene Ther., 10.1089/hgt.2008.124
Wu, 2010, Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications, Int. J. Cancer, 127, 1741, 10.1002/ijc.25489
Wu, 2010, The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells, J. Cell. Physiol., 223, 178, 10.1002/jcp.22026
Wu, 2011, The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation, Leukemia
Girnita, 2011, Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor, Oncogene
Coffelt, 2009, Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells, Mol. Cancer Res., 7, 907, 10.1158/1541-7786.MCR-08-0326
Weber, 2009, Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer, Breast Cancer Res., 11, R6, 10.1186/bcr2221
Popsueva, 1996, A novel murine cathelin-like protein expressed in bone marrow, FEBS Lett., 391, 5, 10.1016/0014-5793(96)00692-8
Nagaoka, 1997, Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation, J. Biol. Chem., 272, 22742, 10.1074/jbc.272.36.22742
Huttner, 1998, Localization and genomic organization of sheep antimicrobial peptide genes, Gene, 206, 85, 10.1016/S0378-1119(97)00569-6
Wu, 1999, Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity, Infect. Immun., 67, 439, 10.1128/IAI.67.1.439-442.1999
Scocchi, 1999, Novel cathelicidins in horse leukocytes(1), FEBS Lett., 457, 459, 10.1016/S0014-5793(99)01097-2
Hao, 2011, Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate, Amino Acids
Anderson, 2008, Antimicrobial fragments of the pro-region of cathelicidins and other immune peptides, Biotechnol. Lett., 30, 813, 10.1007/s10529-007-9628-7
Hase, 2002, Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium, Infect. Immun., 70, 953, 10.1128/IAI.70.2.953-963.2002
Bals, 1998, The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface, Proc. Natl. Acad. Sci. USA, 95, 9541, 10.1073/pnas.95.16.9541
Frohm, 1999, The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6, Infect. Immun., 67, 2561, 10.1128/IAI.67.5.2561-2566.1999
Frohm, 1997, The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders, J. Biol. Chem., 272, 15258, 10.1074/jbc.272.24.15258
Kim, 2009, The effect of calcipotriol on the expression of human beta defensin-2 and LL-37 in cultured human keratinocytes, Clin. Dev. Immunol., 2009, 645898, 10.1155/2009/645898
Braff, 2005, Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies, J. Invest. Dermatol., 124, 394, 10.1111/j.0022-202X.2004.23443.x
Sorensen, 1997, The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils, Blood, 90, 2796, 10.1182/blood.V90.7.2796
Koon, 2011, Cathelicidin signaling via the Toll-like receptor protects against colitis in mice, Gastroenterology, 141, 1852, 10.1053/j.gastro.2011.06.079
Yang, 2009, Alarmins link neutrophils and dendritic cells, Trends Immunol., 30, 531, 10.1016/j.it.2009.07.004
Di, 2003, Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide, J. Immunol., 170, 2274, 10.4049/jimmunol.170.5.2274
Sorensen, 2001, Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3, Blood, 97, 3951, 10.1182/blood.V97.12.3951
Sigurdardottir, 2012, The anti-microbial peptide LL-37 modulates immune responses in the palatine tonsils where it is exclusively expressed by neutrophils and a subset of dendritic cells, Clin. Immunol., 142, 139, 10.1016/j.clim.2011.09.013
Sonawane, 2011, Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages, Cell. Microbiol., 13, 1601, 10.1111/j.1462-5822.2011.01644.x
Rivas-Santiago, 2008, Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells, Infect. Immun., 76, 935, 10.1128/IAI.01218-07
Agerberth, 2000, The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations, Blood, 96, 3086, 10.1182/blood.V96.9.3086
Morizane, 2010, Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid, J. Invest. Dermatol., 130, 1297, 10.1038/jid.2009.435
Sieprawska-Lupa, 2004, Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases, Antimicrob. Agents Chemother., 48, 4673, 10.1128/AAC.48.12.4673-4679.2004
Park, 2011, Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway, J. Biol. Chem., 286, 34121, 10.1074/jbc.M111.250431
Gombart, 2005, Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3, FASEB J., 19, 1067, 10.1096/fj.04-3284com
Realegeno, 2011, Shedding light on the vitamin D-tuberculosis-HIV connection, Proc. Natl. Acad. Sci. USA, 108, 18861, 10.1073/pnas.1116513108
Gombart, 2009, The vitamin D-antimicrobial peptide pathway and its role in protection against infection, Future Microbiol., 4, 1151, 10.2217/fmb.09.87
Koeffler, 1985, Gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages, Biochem. Biophys. Res. Commun., 127, 596, 10.1016/S0006-291X(85)80202-3
Liu, 2006, Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science, 311, 1770, 10.1126/science.1123933
Aberg, 2007, Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice, J. Clin. Invest., 117, 3339, 10.1172/JCI31726
Chakraborty, 2008, Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells, Cell. Microbiol., 10, 2520, 10.1111/j.1462-5822.2008.01227.x
Williams, 2009, Transmigration across activated endothelium induces transcriptional changes, inhibits apoptosis, and decreases antimicrobial protein expression in human monocytes, J. Leukoc. Biol., 86, 1331, 10.1189/jlb.0209062
Sarker, 2011, Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia a potential therapeutic strategy, PLoS One, 6, e20637, 10.1371/journal.pone.0020637
Misawa, 2009, Vitamin D(3) induces expression of human cathelicidin antimicrobial peptide 18 in newborns, Int. J. Hematol., 90, 561, 10.1007/s12185-009-0452-9
Alvarez-Rodriguez, 2012, Age and low levels of circulating vitamin D are associated with impaired innate immune function, J. Leukoc. Biol., 91, 829, 10.1189/jlb.1011523
Davidopoulou, 2012, Salivary concentration of the antimicrobial peptide LL-37 in children, Arch. Oral Biol., 57, 865, 10.1016/j.archoralbio.2012.01.008
Kida, 2006, Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1, Mol. Immunol., 43, 1972, 10.1016/j.molimm.2005.11.014
Steinmann, 2009, Phenylbutyrate induces antimicrobial peptide expression, Antimicrob. Agents Chemother., 53, 5127, 10.1128/AAC.00818-09
Peric, 2008, IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes, J. Immunol., 181, 8504, 10.4049/jimmunol.181.12.8504
Chakraborty, 2009, CAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor, J. Biol. Chem., 284, 21810, 10.1074/jbc.M109.001180
Wimley, 1994, Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores, Protein Sci., 3, 1362, 10.1002/pro.5560030902
Harwig, 1996, Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations, Eur. J. Biochem., 240, 352, 10.1111/j.1432-1033.1996.0352h.x
Andreeva-Kovalevskaya, 2008, Pore-forming proteins and adaptation of living organisms to environmental conditions, Biochemistry (Mosc.), 73, 1473, 10.1134/S0006297908130087
Ganz, 2003, Defensins: antimicrobial peptides of innate immunity, Nat. Rev. Immunol., 3, 710, 10.1038/nri1180
Oppenheim, 2003, Roles of antimicrobial peptides such as defensins in innate and adaptive immunity, Ann. Rheum. Dis., 62, ii17
Nicolas, 2009, Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides, FEBS J., 276, 6483, 10.1111/j.1742-4658.2009.07359.x
Oren, 1999, Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity, Biochem. J., 341, 501, 10.1042/0264-6021:3410501
Tossi, 1994, Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes, FEBS Lett., 339, 108, 10.1016/0014-5793(94)80395-1
Porcelli, 2008, NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles, Biochemistry, 47, 5565, 10.1021/bi702036s
Li, 2006, Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region, J. Am. Chem. Soc., 128, 5776, 10.1021/ja0584875
Wang, 2008, Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles, J. Biol. Chem., 283, 32637, 10.1074/jbc.M805533200
Saiman, 2001, Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis, Antimicrob. Agents Chemother., 45, 2838, 10.1128/AAC.45.10.2838-2844.2001
Boehmer, 2011, Evaluation of protein expression in bovine bronchoalveolar fluid following challenge with Mannheimia haemolytica, Proteomics, 11, 3685, 10.1002/pmic.201000710
Lisanby, 2008, Cathelicidin administration protects mice from Bacillus anthracis spore challenge, J. Immunol., 181, 4989, 10.4049/jimmunol.181.7.4989
Sambri, 2002, Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum, J. Antimicrob. Chemother., 50, 895, 10.1093/jac/dkf220
Thomas-Virnig, 2009, Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue, Mol. Ther., 17, 562, 10.1038/mt.2008.289
Scapinello, 2011, Bactericidal activity of porcine neutrophil secretions, Vet. Immunol. Immunopathol., 139, 113, 10.1016/j.vetimm.2010.09.004
Krahulec, 2010, High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli, Appl. Microbiol. Biotechnol., 88, 167, 10.1007/s00253-010-2736-7
McMahon, 2011, Vitamin D-mediated induction of innate immunity in gingival epithelial cells, Infect. Immun., 79, 2250, 10.1128/IAI.00099-11
Isogai, 2003, Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues, Oral Microbiol. Immunol., 18, 329, 10.1034/j.1399-302X.2003.00083.x
Dorschner, 2001, Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus, J. Invest. Dermatol., 117, 91, 10.1046/j.1523-1747.2001.01340.x
Dudal, 2006, Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis, J. Immunol., 177, 5533, 10.4049/jimmunol.177.8.5533
Wang, 2004, Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation, Antimicrob. Agents Chemother., 48, 2097, 10.1128/AAC.48.6.2097-2100.2004
Martineau, 2007, IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37, J. Immunol., 178, 7190, 10.4049/jimmunol.178.11.7190
Kanthawong, 2009, In vitro susceptibility of Burkholderia pseudomallei to antimicrobial peptides, Int. J. Antimicrob. Agents, 34, 309, 10.1016/j.ijantimicag.2009.05.012
Ouhara, 2005, Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells, J. Antimicrob. Chemother., 55, 888, 10.1093/jac/dki103
Kanthawong, 2010, Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis, Int. J. Antimicrob. Agents, 36, 447, 10.1016/j.ijantimicag.2010.06.031
Kim, 2009, Antibacterial activity of recombinant hCAP18/LL37 protein secreted from Pichia pastoris, J. Microbiol., 47, 358, 10.1007/s12275-009-0131-9
Tanaka, 2000, Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium, Oral Microbiol. Immunol., 15, 226, 10.1034/j.1399-302x.2000.150403.x
Rieg, 2010, Differential activity of innate defense antimicrobial peptides against Nocardia species, BMC Microbiol., 10, 61, 10.1186/1471-2180-10-61
Lee, 2008, Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes, J. Invest. Dermatol., 128, 1863, 10.1038/sj.jid.5701235
Gudmundsson, 2010, Battle and balance at mucosal surfaces–the story of Shigella and antimicrobial peptides, Biochem. Biophys. Res. Commun., 396, 116, 10.1016/j.bbrc.2010.03.081
Ohta, 2011, Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities, J. Neuroimmunol., 233, 37, 10.1016/j.jneuroim.2010.11.009
Lysenko, 2000, Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract, Infect. Immun., 68, 1664, 10.1128/IAI.68.3.1664-1671.2000
Lee, 2010, Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens, Int. J. Antimicrob. Agents, 35, 138, 10.1016/j.ijantimicag.2009.09.024
Puklo, 2008, Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria, Oral Microbiol. Immunol., 23, 328, 10.1111/j.1399-302X.2008.00433.x
Galvan, 2008, Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin, Infect. Immun., 76, 1456, 10.1128/IAI.01197-07
Thennarasu, 2010, Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37, Biophys. J., 98, 248, 10.1016/j.bpj.2009.09.060
Braff, 2005, Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities, J. Immunol., 174, 4271, 10.4049/jimmunol.174.7.4271
Nagaoka, 2002, Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues, Clin. Diagn. Lab. Immunol., 9, 972
Nell, 2006, Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application, Peptides, 27, 649, 10.1016/j.peptides.2005.09.016
Sochacki, 2011, Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37, Proc. Natl. Acad. Sci. USA, 108, E77, 10.1073/pnas.1101130108
Lee, 2011, Transmembrane pores formed by human antimicrobial peptide LL-37, Biophys. J., 100, 1688, 10.1016/j.bpj.2011.02.018
Henzler Wildman, 2003, Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37, Biochemistry, 42, 6545, 10.1021/bi0273563
Ciornei, 2005, Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37, Antimicrob. Agents Chemother., 49, 2845, 10.1128/AAC.49.7.2845-2850.2005
Sandgren, 2004, The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis, J. Biol. Chem., 279, 17951, 10.1074/jbc.M311440200
Lande, 2007, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide, Nature, 449, 564, 10.1038/nature06116
Lai, 2011, LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs, PLoS One, 6, e26632, 10.1371/journal.pone.0026632
Byfield, 2011, Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa, J. Immunol., 10.4049/jimmunol.1102185
Cobo, 2011, Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing, Infect. Immun.
Gronberg, 2011, Stability of the cathelicidin peptide LL-37 in a non-healing wound environment, Acta Derm. Venereol., 91, 511, 10.2340/00015555-1102
Majchrzykiewicz, 2010, Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin, Antimicrob. Agents Chemother., 54, 440, 10.1128/AAC.00769-09
Benincasa, 2006, Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts, J. Antimicrob. Chemother., 58, 950, 10.1093/jac/dkl382
den Hertog, 2005, Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane, Biochem. J., 388, 689, 10.1042/BJ20042099
Kurosaka, 2005, Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant, J. Immunol., 174, 6257, 10.4049/jimmunol.174.10.6257
Bianchi, 2007, DAMPs, PAMPs and alarmins: all we need to know about danger, J. Leukoc. Biol., 81, 1, 10.1189/jlb.0306164
Fu, 2006, Ligand recognition and activation of formyl peptide receptors in neutrophils, J. Leukoc. Biol., 79, 247, 10.1189/jlb.0905498
De, 2000, LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells, J. Exp. Med., 192, 1069, 10.1084/jem.192.7.1069
Zhang, 2009, Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils, Eur. J. Immunol., 39, 3181, 10.1002/eji.200939496
Subramanian, 2011, Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization, J. Biol. Chem., 286, 44739, 10.1074/jbc.M111.277152
Brandenburg, 2010, Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathways, Mol. Immunol., 47, 1905, 10.1016/j.molimm.2010.03.012
Ferrari, 2006, The P2X7 receptor: a key player in IL-1 processing and release, J. Immunol., 176, 3877, 10.4049/jimmunol.176.7.3877
Tomasinsig, 2008, The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner, J. Biol. Chem., 283, 30471, 10.1074/jbc.M802185200
Seil, 2010, Regulation by CRAMP of the responses of murine peritoneal macrophages to extracellular ATP, Biochim. Biophys. Acta, 1798, 569, 10.1016/j.bbamem.2009.11.002
Montreekachon, 2011, Involvement of P2X(7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts, J. Periodontal Res., 46, 327, 10.1111/j.1600-0765.2011.01346.x
Lai, 2009, AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense, Trends Immunol., 30, 131, 10.1016/j.it.2008.12.003
Fischer, 2003, EGFR signal transactivation in cancer cells, Biochem. Soc. Trans., 31, 1203, 10.1042/bst0311203
Yin, 2010, LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas, Invest. Ophthalmol. Vis. Sci., 51, 1891, 10.1167/iovs.09-3904
Tjabringa, 2003, The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor, J. Immunol., 171, 6690, 10.4049/jimmunol.171.12.6690
Nijnik, 2012, The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells, J. Leukoc. Biol., 91, 599, 10.1189/jlb.0411191
Nijnik, 2012, Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin, J. Innate. Immun., 4, 377, 10.1159/000335901
Hennessy, 2010, Targeting toll-like receptors: emerging therapeutics?, Nat. Rev. Drug Discovery, 9, 293, 10.1038/nrd3203
Scott, 2002, The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses, J. Immunol., 169, 3883, 10.4049/jimmunol.169.7.3883
Mookherjee, 2009, Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells, Mol. BioSyst., 5, 483, 10.1039/b813787k
Wuerth, 2011, New insights into cathelicidin modulation of adaptive immunity, Eur. J. Immunol., 41, 2817, 10.1002/eji.201142055
Bowdish, 2004, The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes, J. Immunol., 172, 3758, 10.4049/jimmunol.172.6.3758
Wu, 2010, Cathelicidins in inflammation and tissue repair: potential therapeutic applications for gastrointestinal disorders, Acta Pharmacol. Sin., 31, 1118, 10.1038/aps.2010.117
Ju, 2008, Glucosamine, a naturally occurring amino monosaccharide modulates LL-37-induced endothelial cell activation, Int. J. Mol. Med., 22, 657
Mookherjee, 2009, Intracellular receptor for human host defense peptide LL-37 in monocytes, J. Immunol., 183, 2688, 10.4049/jimmunol.0802586
Brown, 2011, Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses, J. Immunol., 186, 5497, 10.4049/jimmunol.1002508
Zughaier, 2005, Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages, Cell. Microbiol., 7, 1251, 10.1111/j.1462-5822.2005.00549.x
Pistolic, 2009, Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway, J. Innate. Immun., 1, 254, 10.1159/000171533
Into, 2010, Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts, Cell. Immunol., 264, 104, 10.1016/j.cellimm.2010.05.005
Pinheiro da, 2009, Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling, Immunol. Cell Biol., 87, 496, 10.1038/icb.2009.19
Alalwani, 2010, The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils, Eur. J. Immunol., 40, 1118, 10.1002/eji.200939275
Shaykhiev, 2010, The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS, FASEB J., 24, 4756, 10.1096/fj.09-151332
Putsep, 2002, Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study, Lancet, 360, 1144, 10.1016/S0140-6736(02)11201-3
Bucki, 2007, Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum, Eur. Respir. J., 29, 624, 10.1183/09031936.00080806
Ganguly, 2009, Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8, J. Exp. Med., 206, 1983, 10.1084/jem.20090480
Nestle, 2005, Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production, J. Exp. Med., 202, 135, 10.1084/jem.20050500
Bandholtz, 2006, Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype, Scand. J. Immunol., 63, 410, 10.1111/j.1365-3083.2006.001752.x
Otte, 2009, Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity, Regul. Pept., 156, 104, 10.1016/j.regpep.2009.03.009
Zasloff, 2009, Antimicrobial peptides and suppression of apoptosis in human skin, J. Invest. Dermatol., 129, 824, 10.1038/jid.2008.455
Barlow, 2010, The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium, Am. J. Respir. Cell Mol. Biol., 43, 692, 10.1165/rcmb.2009-0250OC
Nagaoka, 2006, An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7, J. Immunol., 176, 3044, 10.4049/jimmunol.176.5.3044
Suzuki, 2011, Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells, Int. Immunol., 23, 185, 10.1093/intimm/dxq471
Kim, 2011, LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts, Exp. Dermatol., 20, 843, 10.1111/j.1600-0625.2011.01327.x
Park, 2009, Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37, J. Invest. Dermatol., 129, 843, 10.1038/jid.2008.320
Zhang, 2010, Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes, PLoS One, 5, e13985, 10.1371/journal.pone.0013985